首页 > 最新文献

Journal of minimally invasive gynecology最新文献

英文 中文
Surgical Enhancement With the Placement of Temporary Bilateral Ureteral Stents With Indocyanine Green Injection for All Stages of Endometriosis in vNOTES: Retrospective Cross-Sectional Study 用吲哚菁绿注射液为vNOTES各期子宫内膜异位症植入临时双侧输尿管支架的手术增强疗法:回顾性横断面研究。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.09.365
Daniel Y. Lovell MD , Emily Sendukas MD , Qiannan Yang MD, PhD , Xiaoming Guan MD, PhD

Study Objective

To demonstrate the time to place temporary bilateral stents with indocyanine green (ICG) injection, time to intra-operative identification of bilateral ureters - with and without the use of ICG, and number of times for ICG activation in endometriosis excision surgery.

Design

Retrospective cross-sectional study.

Setting

Single Tertiary Academic Hospital.

Patients

Fifty serial patients with functioning pelvic ureters, who underwent vaginal natural orifice transluminal endoscopic surgery (vNOTES) for all stages of endometriosis excision between September 2023 and May 2024.

Interventions

Placement of temporary bilateral ureteral stents with indocyanine green injection before the start of vNOTES, noting the time needed to identify intra-peritoneal ureters with and without ICG activation, and average number of times ICG was activated for endometriosis excision.

Measurements and Main Results

The median time to place bilateral ureteral stents with ICG injection was 229 seconds. The median time for intra-operative ureteral identification with ICG was 1s (L) and 1s (R). The median time for intra-operative ureteral identification without ICG was 17s (L) and 17s (R). The median time ICG was activated for ureteral identification to perform endometriosis excision was 12 times (L), 11 times (R). From the observations previously described, we share the potential of improved efficiency and efficacy in using ICG in ureteral identification for endometriosis surgery.

Conclusion

Placement of temporary bilateral ureteral stents with ICG has the potential for more efficient ureteral identification even after including time for ureteral stent placement and ICG injection. The upfront time needed to place stents may prove to lead to a safer, more efficient procedure.
目的证明子宫内膜异位症切除手术中注射吲哚菁绿(ICG)放置双侧临时支架的时间、术中识别双侧输尿管的时间--使用和不使用ICG,以及ICG激活的次数:设计:回顾性横断面研究:参与者:50名盆腔输尿管功能正常的序列患者,他们在2023年9月至2024年5月期间接受了阴道自然孔腔内镜手术(vNOTES),进行了各阶段的子宫内膜异位症切除术:干预措施:在vNOTES开始前注射吲哚菁绿,放置临时双侧输尿管支架,记录激活和未激活ICG时确定腹腔内输尿管所需的时间,以及子宫内膜异位症切除术中激活ICG的平均次数:结果:注射 ICG 放置双侧输尿管支架的中位时间为 229 秒。术中输尿管识别 ICG 的中位时间为 1 秒(左)和 1 秒(右)。不使用 ICG 的术中输尿管识别中位时间为 17 秒(左)和 17 秒(右)。为进行子宫内膜异位症切除术而激活 ICG 进行输尿管识别的中位时间为 12 次(左)和 11 次(右)。从之前描述的观察结果来看,我们认为使用 ICG 进行输尿管识别以实施子宫内膜异位症手术具有提高效率和疗效的潜力:结论:使用 ICG 放置临时双侧输尿管支架有可能提高输尿管识别的效率,即使包括输尿管支架放置和 ICG 注射的时间。放置支架所需的前期时间可能会使手术更安全、更高效。
{"title":"Surgical Enhancement With the Placement of Temporary Bilateral Ureteral Stents With Indocyanine Green Injection for All Stages of Endometriosis in vNOTES: Retrospective Cross-Sectional Study","authors":"Daniel Y. Lovell MD ,&nbsp;Emily Sendukas MD ,&nbsp;Qiannan Yang MD, PhD ,&nbsp;Xiaoming Guan MD, PhD","doi":"10.1016/j.jmig.2024.09.365","DOIUrl":"10.1016/j.jmig.2024.09.365","url":null,"abstract":"<div><h3>Study Objective</h3><div>To demonstrate the time to place temporary bilateral stents with indocyanine green (ICG) injection, time to intra-operative identification of bilateral ureters - with and without the use of ICG, and number of times for ICG activation in endometriosis excision surgery.</div></div><div><h3>Design</h3><div>Retrospective cross-sectional study.</div></div><div><h3>Setting</h3><div>Single Tertiary Academic Hospital.</div></div><div><h3>Patients</h3><div>Fifty serial patients with functioning pelvic ureters, who underwent vaginal natural orifice transluminal endoscopic surgery (vNOTES) for all stages of endometriosis excision between September 2023 and May 2024.</div></div><div><h3>Interventions</h3><div>Placement of temporary bilateral ureteral stents with indocyanine green injection before the start of vNOTES, noting the time needed to identify intra-peritoneal ureters with and without ICG activation, and average number of times ICG was activated for endometriosis excision.</div></div><div><h3>Measurements and Main Results</h3><div>The median time to place bilateral ureteral stents with ICG injection was 229 seconds. The median time for intra-operative ureteral identification with ICG was 1s (L) and 1s (R). The median time for intra-operative ureteral identification without ICG was 17s (L) and 17s (R). The median time ICG was activated for ureteral identification to perform endometriosis excision was 12 times (L), 11 times (R). From the observations previously described, we share the potential of improved efficiency and efficacy in using ICG in ureteral identification for endometriosis surgery.</div></div><div><h3>Conclusion</h3><div>Placement of temporary bilateral ureteral stents with ICG has the potential for more efficient ureteral identification even after including time for ureteral stent placement and ICG injection. The upfront time needed to place stents may prove to lead to a safer, more efficient procedure.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 166-170"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence-Based Practice for Minimization of Blood Loss During Laparoscopic Myomectomy: An AAGL Practice Guideline
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.09.021

Study Objective

To provide evidence-based recommendations regarding the use of pre-operative medical adjuncts and intra-operative interventions for reducing blood loss during laparoscopic (conventional or robotic-assisted) myomectomy.

Design

A systematic review and meta-analyses of the relevant literature were performed to develop evidence-based guideline recommendations.

Setting

Published literature.

Patients

Patients undergoing laparoscopic myomectomy.

Interventions

Pre-operative medical adjuncts and intra-operative interventions for reducing blood loss.

Measurements and Main Results

The primary outcome was surgical blood loss. Secondary outcomes were change in hematocrit or hemoglobin and blood transfusion. Additional outcomes included length of procedure, intra- and post-operative complications, conversion to laparotomy, reoperation, readmission, and length of stay. A total of 75 studies fulfilled the eligibility criteria and formed the basis for this practice guideline. Evidence-based recommendations were developed regarding the use of pre-operative medical adjuncts including gonadotropin-releasing hormone agonist and progesterone), as well as intra-operative vasoconstrictors, uterine artery occlusion, electrosurgical devices and barbed suture.

Conclusions

Systematic review and multiple meta-analyses identified moderate evidence supporting the use of 3-month administration of leuprolide acetate prior to myomectomy and intra-operative use of misoprostol, epinephrine, vasopressin, oxytocin, and uterine artery occlusion for reducing blood loss during laparoscopic myomectomy.
{"title":"Evidence-Based Practice for Minimization of Blood Loss During Laparoscopic Myomectomy: An AAGL Practice Guideline","authors":"","doi":"10.1016/j.jmig.2024.09.021","DOIUrl":"10.1016/j.jmig.2024.09.021","url":null,"abstract":"<div><h3>Study Objective</h3><div>To provide evidence-based recommendations regarding the use of pre-operative medical adjuncts and intra-operative interventions for reducing blood loss during laparoscopic (conventional or robotic-assisted) myomectomy.</div></div><div><h3>Design</h3><div>A systematic review and meta-analyses of the relevant literature were performed to develop evidence-based guideline recommendations.</div></div><div><h3>Setting</h3><div>Published literature.</div></div><div><h3>Patients</h3><div>Patients undergoing laparoscopic myomectomy.</div></div><div><h3>Interventions</h3><div>Pre-operative medical adjuncts and intra-operative interventions for reducing blood loss.</div></div><div><h3>Measurements and Main Results</h3><div>The primary outcome was surgical blood loss. Secondary outcomes were change in hematocrit or hemoglobin and blood transfusion. Additional outcomes included length of procedure, intra- and post-operative complications, conversion to laparotomy, reoperation, readmission, and length of stay. A total of 75 studies fulfilled the eligibility criteria and formed the basis for this practice guideline. Evidence-based recommendations were developed regarding the use of pre-operative medical adjuncts including gonadotropin-releasing hormone agonist and progesterone), as well as intra-operative vasoconstrictors, uterine artery occlusion, electrosurgical devices and barbed suture.</div></div><div><h3>Conclusions</h3><div>Systematic review and multiple meta-analyses identified moderate evidence supporting the use of 3-month administration of leuprolide acetate prior to myomectomy and intra-operative use of misoprostol, epinephrine, vasopressin, oxytocin, and uterine artery occlusion for reducing blood loss during laparoscopic myomectomy.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 113-132"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143347044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perforated Intrauterine Device in the Abdomen: Leave or Retrieve? 腹部宫内节育器穿孔:留下还是取出?
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.07.025
Erin Seto MSc , Emily N. Liu , Nigel Pereira MD
{"title":"Perforated Intrauterine Device in the Abdomen: Leave or Retrieve?","authors":"Erin Seto MSc ,&nbsp;Emily N. Liu ,&nbsp;Nigel Pereira MD","doi":"10.1016/j.jmig.2024.07.025","DOIUrl":"10.1016/j.jmig.2024.07.025","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 103-104"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Societies
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/S1553-4650(25)00004-4
{"title":"International Societies","authors":"","doi":"10.1016/S1553-4650(25)00004-4","DOIUrl":"10.1016/S1553-4650(25)00004-4","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Page A2"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143343531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D Imaging Reconstruction and Laparoscopic Robotic Surgery Approach to Disseminated Peritoneal Leiomyomatosis 三维成像重建和腹腔镜机器人手术治疗播散性腹膜黏液瘤病。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.10.003
Giuseppe D'Angelo MD , Gaby N. Moawad MD , Attilio Di Spiezio Sardo PhD , Mario Ascione MD , Roberta Danzi MD , Pierluigi Giampaolino PhD , Giuseppe Bifulco PhD

Study Objective

This video article explores the synergistic approach of 3-dimensional (3D) imaging reconstruction and laparoscopic robotic surgery for the management of a complex case of disseminated peritoneal leiomyomatosis [1]. The primary focus lies in the capability of the reconstruction model to provide diagnostic support to identify myomas during surgical procedures, potentially enhancing surgical precision, reducing operating times, minimizing uterine incisions, and limiting blood loss. 3D imaging reconstruction techniques were used to facilitate the identification of multiple parasitic and nonserosal myomas, which is particularly challenging when operating with a robotic surgical platform that lacks haptic feedback.

Design

A case report design was used, focusing on a 43-year-old nulliparous infertile woman with multiple symptomatic uterine myomas. Our institution has made a further diagnosis of disseminated peritoneal leiomyomatosis [2,3].

Setting

Tertiary referral center.

Interventions

Owing to the widespread nature of peritoneal leiomyomatosis and numerous uterine myomas, robotic surgery was considered a preferable option based on our experience to operate within confined anatomic spaces. 3D imaging reconstruction technology was used for preoperative and intraoperative planning, enabling precise determination of the myomas’ location, size, and volume obtained through magnetic resonance imaging. Real-time 3D imaging guided rapid myoma localization and surgical strategy adjustment [4,5]. The procedure resulted in the removal of 15 myomas, with minimal blood loss (250 mL) and a total operative time of 120 minutes. Multilayer running hysterorrhaphy was performed using a barbed monofilament suture to ensure effective hemostasis, incorporating serosal introflection to reduce the risk of postoperative adhesion development.

Conclusion

The combined approach of 3D imaging reconstruction and laparoscopic robotic surgery holds significant potential for the management of disseminated peritoneal leiomyomatosis. This approach can overcome some robotic surgery limitations, particularly the absence of haptic feedback, providing accurate preoperative planning and real-time intraoperative guidance, facilitating efficient myoma localization, minimizing uterine incisions, and reducing blood loss. Further research is needed to fully evaluate the clinical impact of this promising technology.
目的:本视频文章探讨了三维成像重建和腹腔镜机器人手术的协同方法,用于治疗一例复杂的播散性腹膜子宫肌瘤病(1)。主要重点在于重建模型能够在手术过程中为识别子宫肌瘤提供诊断支持,从而有可能提高手术精度、缩短手术时间、最大限度地减少子宫切口并限制失血量。三维成像重建技术用于帮助识别多发性寄生肌瘤和非骨膜肌瘤,这在使用缺乏触觉反馈的机器人手术平台进行手术时尤其具有挑战性:环境:三级转诊中心:采用病例报告设计,重点关注一名43岁的无阴道不孕妇女,她患有多个症状性子宫肌瘤。我院进一步诊断为播散性腹膜子宫肌瘤病(4-5):由于腹膜白肌瘤病的广泛性和子宫肌瘤的多发性,根据我们在狭窄解剖空间内进行手术的经验,机器人手术被认为是一种可取的选择。我们在术前和术中规划时采用了三维成像重建技术,通过核磁共振成像精确确定了肌瘤的位置、大小和体积。实时三维成像引导肌瘤快速定位和手术策略调整(2-3)。该手术切除了 15 个肌瘤,失血量极少(250 毫升),手术总时间为 120 分钟。使用带倒刺的单丝缝合线进行多层流水子宫肌瘤剔除术,以确保有效止血,并结合浆膜导入以降低术后粘连发生的风险:结论:三维成像重建和腹腔镜机器人手术相结合的方法在治疗播散性腹膜白肌瘤病方面潜力巨大。这种方法可以克服机器人手术的一些局限性,特别是缺乏触觉反馈,提供准确的术前计划和实时术中指导,促进有效的肌瘤定位,最大限度地减少子宫切口,并降低失血量。要全面评估这项前景广阔的技术对临床的影响,还需要进一步的研究。
{"title":"3D Imaging Reconstruction and Laparoscopic Robotic Surgery Approach to Disseminated Peritoneal Leiomyomatosis","authors":"Giuseppe D'Angelo MD ,&nbsp;Gaby N. Moawad MD ,&nbsp;Attilio Di Spiezio Sardo PhD ,&nbsp;Mario Ascione MD ,&nbsp;Roberta Danzi MD ,&nbsp;Pierluigi Giampaolino PhD ,&nbsp;Giuseppe Bifulco PhD","doi":"10.1016/j.jmig.2024.10.003","DOIUrl":"10.1016/j.jmig.2024.10.003","url":null,"abstract":"<div><h3>Study Objective</h3><div>This video article explores the synergistic approach of 3-dimensional (3D) imaging reconstruction and laparoscopic robotic surgery for the management of a complex case of disseminated peritoneal leiomyomatosis [<span><span>1</span></span>]. The primary focus lies in the capability of the reconstruction model to provide diagnostic support to identify myomas during surgical procedures, potentially enhancing surgical precision, reducing operating times, minimizing uterine incisions, and limiting blood loss. 3D imaging reconstruction techniques were used to facilitate the identification of multiple parasitic and nonserosal myomas, which is particularly challenging when operating with a robotic surgical platform that lacks haptic feedback.</div></div><div><h3>Design</h3><div>A case report design was used, focusing on a 43-year-old nulliparous infertile woman with multiple symptomatic uterine myomas. Our institution has made a further diagnosis of disseminated peritoneal leiomyomatosis [<span><span>2</span></span>,<span><span>3</span></span>].</div></div><div><h3>Setting</h3><div>Tertiary referral center.</div></div><div><h3>Interventions</h3><div>Owing to the widespread nature of peritoneal leiomyomatosis and numerous uterine myomas, robotic surgery was considered a preferable option based on our experience to operate within confined anatomic spaces. 3D imaging reconstruction technology was used for preoperative and intraoperative planning, enabling precise determination of the myomas’ location, size, and volume obtained through magnetic resonance imaging. Real-time 3D imaging guided rapid myoma localization and surgical strategy adjustment [<span><span>4</span></span>,<span><span>5</span></span>]. The procedure resulted in the removal of 15 myomas, with minimal blood loss (250 mL) and a total operative time of 120 minutes. Multilayer running hysterorrhaphy was performed using a barbed monofilament suture to ensure effective hemostasis, incorporating serosal introflection to reduce the risk of postoperative adhesion development.</div></div><div><h3>Conclusion</h3><div>The combined approach of 3D imaging reconstruction and laparoscopic robotic surgery holds significant potential for the management of disseminated peritoneal leiomyomatosis. This approach can overcome some robotic surgery limitations, particularly the absence of haptic feedback, providing accurate preoperative planning and real-time intraoperative guidance, facilitating efficient myoma localization, minimizing uterine incisions, and reducing blood loss. Further research is needed to fully evaluate the clinical impact of this promising technology.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 111-112"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Antibiotic Choice and Postoperative Infectious Complications in Pelvic Organ Prolapse Surgery 盆腔器官脱垂手术的围手术期抗生素选择与术后感染并发症。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.10.004
Margot Le Neveu MD , Erica Qiao MD , Stephen Rhodes PhD , Anne Sammarco MD, MPH , Adonis Hijaz MD , David Sheyn MD

Objective

The objective of this study was to determine how rates of postoperative infectious complications after pelvic organ prolapse surgery differ based on perioperative antibiotic administered. In particular, we sought to determine whether anaerobic coverage is associated with reduced rates of infectious complications.

Design

This was a retrospective cohort study.

Setting

Premier Healthcare U.S. national database, a comprehensive all-payer dataset capturing patients from urban and rural nonprofit, community, and teaching hospitals.

Participants

Adult patients who underwent vaginal, laparoscopic, and/or abdominal prolapse surgery with or without hysterectomy from January 2000 to March 2020. Procedures with and without mesh were included.

Interventions

Rates of infectious complications were compared among patients who received guideline-concordant antibiotic regimens, including those with anaerobic coverage. The primary outcome was any surgical site infection within 30 days of surgery without mesh or 90 days of surgery involving mesh.

Results

Among 130,198 prolapse surgeries, the most common antibiotic regimens were cefazolin (n = 97,058, 74.5%), second-generation cephalosporin (n = 16,442, 12.6%), clindamycin + aminoglycoside (n = 8,397, 6.4%) and cefazolin + metronidazole (n = 4,328, 3.3%). On multivariable logistic regression, only clindamycin + aminoglycoside was associated with a higher rate of surgical site infections (OR = 1.37; 95% CI 1.09–1.72) and other infectious morbidity (OR = 1.26; 95% CI 1.12–1.42) when compared to cefazolin alone. The addition of metronidazole to cefazolin was not associated with reduced rates of surgical site infections (OR = 1.09; 95% CI 0.82–1.45). Obesity (OR = 1.22; 95% CI 1.03–1.43), diabetes without complication (OR = 1.30; 95% CI 1.08–1.57), Charlson comorbidity score >0 (OR = 1.24; 95% CI 1.06–1.45), and tobacco use (OR = 1.22, 95% CI 1.05–1.40) were also associated with increased composite surgical site infection.

Conclusion

Compared with cefazolin alone, the use of alternative perioperative antibiotics, including those with anaerobic coverage, was not associated with reduced infectious complications after pelvic organ prolapse surgery in this U.S. national sample.
研究目的本研究旨在确定盆腔器官脱垂手术后感染性并发症的发生率因围手术期使用的抗生素而有所不同。特别是,我们试图确定厌氧菌覆盖是否与感染性并发症发生率的降低有关:设计:这是一项回顾性队列研究:Premier Healthcare 美国国家数据库是一个全面的全付费者数据集,收集了来自城市和农村非营利性医院、社区医院和教学医院的患者:2000 年 1 月至 2020 年 3 月期间接受过阴道、腹腔镜和/或腹部脱垂手术并进行或未进行子宫切除术的成年患者。干预措施:干预措施:比较了接受与指南一致的抗生素治疗方案(包括厌氧菌覆盖方案)的患者的感染性并发症发生率。主要结果为无网片手术后 30 天内或有网片手术后 90 天内的任何手术部位感染:在130,198例脱垂手术中,最常见的抗生素方案是头孢唑林(97,058例,74.5%)、第二代头孢菌素(16,442例,12.6%)、克林霉素+氨基糖苷(8,397例,6.4%)和头孢唑林+甲硝唑(4,328例,3.3%)。在多变量逻辑回归中,与单用头孢唑啉相比,只有克林霉素+氨基糖苷与较高的手术部位感染率(OR 1.37;95% CI 1.09-1.72)和其他感染性发病率(OR 1.26;95% CI 1.12-1.42)相关。在头孢唑啉中添加甲硝唑与手术部位感染率降低无关(OR 1.09;95% CI 0.82 - 1.45)。肥胖(OR=1.22;95% CI 1.03-1.43)、无并发症的糖尿病(OR=1.30;95% CI 1.08-1.57)、Charlson合并症评分大于0(OR=1.24;95% CI 1.06-1.45)和吸烟(OR=1.22,95% CI 1.05-1.40)也与复合手术部位感染增加有关:结论:在这一美国全国样本中,与单纯使用头孢唑啉相比,围手术期使用其他抗生素(包括厌氧菌覆盖的抗生素)与盆腔器官脱垂手术后感染并发症的减少无关。
{"title":"Perioperative Antibiotic Choice and Postoperative Infectious Complications in Pelvic Organ Prolapse Surgery","authors":"Margot Le Neveu MD ,&nbsp;Erica Qiao MD ,&nbsp;Stephen Rhodes PhD ,&nbsp;Anne Sammarco MD, MPH ,&nbsp;Adonis Hijaz MD ,&nbsp;David Sheyn MD","doi":"10.1016/j.jmig.2024.10.004","DOIUrl":"10.1016/j.jmig.2024.10.004","url":null,"abstract":"<div><h3>Objective</h3><div>The objective of this study was to determine how rates of postoperative infectious complications after pelvic organ prolapse surgery differ based on perioperative antibiotic administered. In particular, we sought to determine whether anaerobic coverage is associated with reduced rates of infectious complications.</div></div><div><h3>Design</h3><div>This was a retrospective cohort study.</div></div><div><h3>Setting</h3><div>Premier Healthcare U.S. national database, a comprehensive all-payer dataset capturing patients from urban and rural nonprofit, community, and teaching hospitals.</div></div><div><h3>Participants</h3><div>Adult patients who underwent vaginal, laparoscopic, and/or abdominal prolapse surgery with or without hysterectomy from January 2000 to March 2020. Procedures with and without mesh were included.</div></div><div><h3>Interventions</h3><div>Rates of infectious complications were compared among patients who received guideline-concordant antibiotic regimens, including those with anaerobic coverage. The primary outcome was any surgical site infection within 30 days of surgery without mesh or 90 days of surgery involving mesh.</div></div><div><h3>Results</h3><div>Among 130,198 prolapse surgeries, the most common antibiotic regimens were cefazolin (n = 97,058, 74.5%), second-generation cephalosporin (n = 16,442, 12.6%), clindamycin + aminoglycoside (n = 8,397, 6.4%) and cefazolin + metronidazole (n = 4,328, 3.3%). On multivariable logistic regression, only clindamycin + aminoglycoside was associated with a higher rate of surgical site infections (OR = 1.37; 95% CI 1.09–1.72) and other infectious morbidity (OR = 1.26; 95% CI 1.12–1.42) when compared to cefazolin alone. The addition of metronidazole to cefazolin was not associated with reduced rates of surgical site infections (OR = 1.09; 95% CI 0.82–1.45). Obesity (OR = 1.22; 95% CI 1.03–1.43), diabetes without complication (OR = 1.30; 95% CI 1.08–1.57), Charlson comorbidity score &gt;0 (OR = 1.24; 95% CI 1.06–1.45), and tobacco use (OR = 1.22, 95% CI 1.05–1.40) were also associated with increased composite surgical site infection.</div></div><div><h3>Conclusion</h3><div>Compared with cefazolin alone, the use of alternative perioperative antibiotics, including those with anaerobic coverage, was not associated with reduced infectious complications after pelvic organ prolapse surgery in this U.S. national sample.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 185-193.e6"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142467862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Work Related Pain in Gynecologic Surgeons - A National Survey.
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2025.01.014
Riley J Young, Alexis Allen, Donald McIntire, Erica F Robinson, Olga Bougie, Kimberly A Kho

Study objective: The objectives of the study are to 1) ascertain the prevalence of work-related pain amongst gynecologic surgeons, 2) describe risk factors and sequelae of pain and 3) assess the need for an ergonomic curriculum.

Study design: Survey study.

Setting: The survey was electronically administered.

Participants: Gynecologic surgery subspecialists and fellows in training were included, as well as Ob/Gyn Specialists who perform gynecologic surgery.

Measurements: A 38-question anonymous survey was developed from available ergonomic literature and had three main sections 1) demographic information, 2) pain history and 3) ergonomic education.

Main results: 305 gynecologic surgeons participated. 76.7% identified as female. Most respondents were Minimally Invasive Gynecologic Surgeons (64.6%) with a primary surgical modality of conventional laparoscopy (65.6%). 95.7% of respondents reported pain during or after surgery. Female surgeons (p = .018), shorter surgeons (OR = 2.4, 95% CI [1.1, 5.4]), and those with a smaller glove size (p = .025) were more likely to report severe pain. Surgeons who reported worse pain were more likely to seek treatment (p = .007) and take time off from operating (p < .001). 79.4% of respondents report engaging in a variety of interventions to treat surgery-related pain. Due to pain, 23.9% report changing surgical modality and 62.5% of surgeons are concerned about their ability to operate in the future. 61.3% of surgeons did not feel confident in their ability to ergonomically set up their operating room. 98.0% recommend formal ergonomic training for residents.

Conclusions: Surgeons are at risk for work-related pain. Gynecologic surgeons are an understudied population with specific ergonomic challenges. In this national survey of high-volume gynecologic surgeons of various subspecialities, we report a high rate of surgery-related pain, significant clinical and nonclinical sequelae of pain, and demonstrate a need for implementing and improving ergonomic training for Obstetrics and Gynecology trainees.

{"title":"Work Related Pain in Gynecologic Surgeons - A National Survey.","authors":"Riley J Young, Alexis Allen, Donald McIntire, Erica F Robinson, Olga Bougie, Kimberly A Kho","doi":"10.1016/j.jmig.2025.01.014","DOIUrl":"https://doi.org/10.1016/j.jmig.2025.01.014","url":null,"abstract":"<p><strong>Study objective: </strong>The objectives of the study are to 1) ascertain the prevalence of work-related pain amongst gynecologic surgeons, 2) describe risk factors and sequelae of pain and 3) assess the need for an ergonomic curriculum.</p><p><strong>Study design: </strong>Survey study.</p><p><strong>Setting: </strong>The survey was electronically administered.</p><p><strong>Participants: </strong>Gynecologic surgery subspecialists and fellows in training were included, as well as Ob/Gyn Specialists who perform gynecologic surgery.</p><p><strong>Measurements: </strong>A 38-question anonymous survey was developed from available ergonomic literature and had three main sections 1) demographic information, 2) pain history and 3) ergonomic education.</p><p><strong>Main results: </strong>305 gynecologic surgeons participated. 76.7% identified as female. Most respondents were Minimally Invasive Gynecologic Surgeons (64.6%) with a primary surgical modality of conventional laparoscopy (65.6%). 95.7% of respondents reported pain during or after surgery. Female surgeons (p = .018), shorter surgeons (OR = 2.4, 95% CI [1.1, 5.4]), and those with a smaller glove size (p = .025) were more likely to report severe pain. Surgeons who reported worse pain were more likely to seek treatment (p = .007) and take time off from operating (p < .001). 79.4% of respondents report engaging in a variety of interventions to treat surgery-related pain. Due to pain, 23.9% report changing surgical modality and 62.5% of surgeons are concerned about their ability to operate in the future. 61.3% of surgeons did not feel confident in their ability to ergonomically set up their operating room. 98.0% recommend formal ergonomic training for residents.</p><p><strong>Conclusions: </strong>Surgeons are at risk for work-related pain. Gynecologic surgeons are an understudied population with specific ergonomic challenges. In this national survey of high-volume gynecologic surgeons of various subspecialities, we report a high rate of surgery-related pain, significant clinical and nonclinical sequelae of pain, and demonstrate a need for implementing and improving ergonomic training for Obstetrics and Gynecology trainees.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginoscopic Resection of an Obstructed Right Hemivagina in Obstructed Hemivagina and Ipsilateral Renal Agenesis Syndrome 阴道镜下切除 OHVIRA 综合征的右半阴道阻塞。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.07.022
Kharmen A. Bharucha MD , Camille Ladanyi MD , Olga Fajardo MD
{"title":"Vaginoscopic Resection of an Obstructed Right Hemivagina in Obstructed Hemivagina and Ipsilateral Renal Agenesis Syndrome","authors":"Kharmen A. Bharucha MD ,&nbsp;Camille Ladanyi MD ,&nbsp;Olga Fajardo MD","doi":"10.1016/j.jmig.2024.07.022","DOIUrl":"10.1016/j.jmig.2024.07.022","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 100-102"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141859998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' Reply 作者回复。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.10.009
Huihui Chen MD, Min Yao MD, Yizhi Wang MD, Xipeng Wang MD, PhD
{"title":"Authors' Reply","authors":"Huihui Chen MD,&nbsp;Min Yao MD,&nbsp;Yizhi Wang MD,&nbsp;Xipeng Wang MD, PhD","doi":"10.1016/j.jmig.2024.10.009","DOIUrl":"10.1016/j.jmig.2024.10.009","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 198-200"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Minimally Invasive Gynecologic Surgery Subspecialty Training on Outcomes of Benign Laparoscopic Hysterectomy: A Retrospective Cohort Study 微创妇科手术亚专业培训对良性腹腔镜子宫切除术结果的影响--一项回顾性队列研究。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jmig.2024.09.012
Raanan Meyer MD , Rebecca J. Schneyer MD , Kacey M. Hamilton MD , Gabriel Levin MD , Mireille D. Truong MD , Matthew T. Siedhoff MD, MSCR , Kelly N. Wright MD

Study Objective

To compare surgical outcomes among patients undergoing minimally invasive hysterectomy (MIH), laparoscopic or robotic, with minimally invasive gynecologic surgery (MIGS) subspecialists, gynecologic oncologists (GOs), or general obstetrician/gynecologists (OB/GYNs).

Design

Retrospective cohort study.

Setting

Quaternary care academic hospital.

Patients

Patients undergoing MIH for benign indications from March 2015 to March 2020 were included.

Interventions

MIH.

Measurements and Main Results

The primary outcome was the odds of a composite of any intra- or postoperative complications within 30 days of surgery by surgeons’ group. A total of 728 MIHs were performed during the study period and constituted the cohort, of which 368 (50.5%) were performed by MIGSs, 144 (19.8%) by GOs, and 216 (29.7%) by OB/GYNs. Intra- and postoperative complications occurred in 11.7% of the MIGS group, 22.9% of the GO group (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.36–3.71), and 25.9% of the OB/GYN group (OR, 2.65; 95% CI, 1.70–4.12). Major intra- or postoperative complications were associated with surgeons’ groups (OR, 7.02; 95% CI, 2.67–18.47, and OR, 6.84; 95% CI, 2.73–17.16 for GO and OB/GYN compared with MIGS, respectively). Intraoperative complication rates were significantly lower for MIGS surgeons (1.4%) than for GOs (9.0%; OR, 7.21; 95% CI, 2.52–20.60) and OB/GYNs (9.7%; OR, 7.82; 95% CI, 2.90–21.06). There was a higher odd of postoperative complications for OB/GYNs than MIGS (18.5% vs 10.9%; OR, 1.86; 95% CI, 1.16–3.00). Rates of conversion to laparotomy were lowest among MIGS surgeons (0.3%) compared with GOs (7.6%) and OB/GYNs (7.9%). Estimated blood loss 90th percentile or higher and surgery time 90th percentile or higher were more common for OB/GYNs than MIGS surgeons (OR, 2.12; 95% CI, 1.07–4.22; OR, 2.48; 95% CI, 1.49–4.12, respectively).

Conclusion

Fellowship-trained MIGS subspecialists had improved surgical outcomes for benign MIH compared with GOs and OB/GYNs, with lower rates of perioperative complications and fewer conversions to laparotomy.
研究目的比较接受腹腔镜或机器人微创子宫切除术(MIH)的患者与微创妇科手术(MIGS)亚专科医生、妇科肿瘤学家(GO)或普通妇产科医生(OB/GYN)的手术效果:设计:回顾性队列研究:患者或参与者:纳入2015年3月至2020年3月期间因良性适应症接受MIH的患者:测量和主要结果:主要结果是手术后30天内出现任何术中或术后并发症的几率,按外科医生分组。研究期间共进行了728例MIH,其中368例(50.5%)由妇产科医生实施,144例(19.8%)由普通外科医生实施,216例(29.7%)由妇产科医生实施。术中和术后并发症的发生率分别为:MIGS 组 11.7%、GO 组 22.9%(OR 2.25,95%CI 1.36-3.71)和 OB/GYN 组 25.9%(OR 2.65,95%CI 1.70-4.12)。主要术中或术后并发症与外科医生组别有关(与 MIGS 相比,GO 组和 OB/GYN 组的 OR 分别为 7.02 95%CI 2.67-18.47 和 6.84 95%CI 2.73-17.16)。MIGS 外科医生的术中并发症发生率(1.4%)明显低于 GO 外科医生(9.0%,OR 7.21 95%CI 2.52-20.60)和 OB/GYN 外科医生(9.7%,OR 7.82 95%CI 2.90-21.06)。妇产科医生的术后并发症发生率高于妇产科医生(18.5% 对 10.9%,OR 1.86 95%CI 1.16-3.00)。与普通外科医生(7.6%)和妇产科医生(7.9%)相比,妇产科医生转为开腹手术的比例最低(0.3%)。与 MIGS 外科医生相比,估计失血量第 90 百分位数或更高和手术时间第 90 百分位数或更高的情况在妇产科医生中更为常见(OR 2.12 95%CI 1.07-4.22;OR 2.48 95%CI 1.49-4.12):经过研究员培训的MIGS亚专科医生与GO和妇产科医生相比,良性MIH的手术效果更好,围手术期并发症发生率更低,转为开腹手术的情况更少。
{"title":"The Impact of Minimally Invasive Gynecologic Surgery Subspecialty Training on Outcomes of Benign Laparoscopic Hysterectomy: A Retrospective Cohort Study","authors":"Raanan Meyer MD ,&nbsp;Rebecca J. Schneyer MD ,&nbsp;Kacey M. Hamilton MD ,&nbsp;Gabriel Levin MD ,&nbsp;Mireille D. Truong MD ,&nbsp;Matthew T. Siedhoff MD, MSCR ,&nbsp;Kelly N. Wright MD","doi":"10.1016/j.jmig.2024.09.012","DOIUrl":"10.1016/j.jmig.2024.09.012","url":null,"abstract":"<div><h3>Study Objective</h3><div>To compare surgical outcomes among patients undergoing minimally invasive hysterectomy (MIH), laparoscopic or robotic, with minimally invasive gynecologic surgery (MIGS) subspecialists, gynecologic oncologists (GOs), or general obstetrician/gynecologists (OB/GYNs).</div></div><div><h3>Design</h3><div>Retrospective cohort study.</div></div><div><h3>Setting</h3><div>Quaternary care academic hospital.</div></div><div><h3>Patients</h3><div>Patients undergoing MIH for benign indications from March 2015 to March 2020 were included.</div></div><div><h3>Interventions</h3><div>MIH.</div></div><div><h3>Measurements and Main Results</h3><div>The primary outcome was the odds of a composite of any intra- or postoperative complications within 30 days of surgery by surgeons’ group. A total of 728 MIHs were performed during the study period and constituted the cohort, of which 368 (50.5%) were performed by MIGSs, 144 (19.8%) by GOs, and 216 (29.7%) by OB/GYNs. Intra- and postoperative complications occurred in 11.7% of the MIGS group, 22.9% of the GO group (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.36–3.71), and 25.9% of the OB/GYN group (OR, 2.65; 95% CI, 1.70–4.12). Major intra- or postoperative complications were associated with surgeons’ groups (OR, 7.02; 95% CI, 2.67–18.47, and OR, 6.84; 95% CI, 2.73–17.16 for GO and OB/GYN compared with MIGS, respectively). Intraoperative complication rates were significantly lower for MIGS surgeons (1.4%) than for GOs (9.0%; OR, 7.21; 95% CI, 2.52–20.60) and OB/GYNs (9.7%; OR, 7.82; 95% CI, 2.90–21.06). There was a higher odd of postoperative complications for OB/GYNs than MIGS (18.5% vs 10.9%; OR, 1.86; 95% CI, 1.16–3.00). Rates of conversion to laparotomy were lowest among MIGS surgeons (0.3%) compared with GOs (7.6%) and OB/GYNs (7.9%). Estimated blood loss 90th percentile or higher and surgery time 90th percentile or higher were more common for OB/GYNs than MIGS surgeons (OR, 2.12; 95% CI, 1.07–4.22; OR, 2.48; 95% CI, 1.49–4.12, respectively).</div></div><div><h3>Conclusion</h3><div>Fellowship-trained MIGS subspecialists had improved surgical outcomes for benign MIH compared with GOs and OB/GYNs, with lower rates of perioperative complications and fewer conversions to laparotomy.</div></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":"32 2","pages":"Pages 143-150"},"PeriodicalIF":3.5,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of minimally invasive gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1